| 08:15 | Idiopathic inflammatory diseases of orbit and ocular adnexa: Histopathological and immunochemical analysis | DAS D, BHATTACHARJEE K, BHATTACHARJEE H | ||||||
| 08:20 | Transcriptomic and proteomic landscape of Vogt-Koyanagi-Harada disease | CHANG Rui | ||||||
|   | ||||||||
| 08:30 | Interleukin-6 receptor (IL-6R) signaling inhibition with satralizumab in thyroid eye disease (TED): phase 3 SatraGO-1 and SatraGO-2 trial design | CORONEL M, EZRA D, COLLINS A, STAN M, HASKOVA Z, KUENZEL T, TRIYATNI M, IDOWU O | ||||||
| 08:35 | IgG4-Related Disease Isolated to the Orbit | ZWETKOFF A, MINGARDO F, KAHANA A, ELNER V M | ||||||
| 08:40 | Evaluation of Imaging in Patients with Posterior Uveitis and Comparative Analysis of Fluorescein and Indocyanine Green Angiography with Spectralis® HRA and Optos | MASSAMBA NM | ||||||
| 08:45 | End of Session | |||||||